ARTICLE | Company News
Valeant, Sanpower deal
January 13, 2017 7:50 PM UTC
Valeant is selling cancer company Dendreon Pharmaceuticals Inc. to Sanpower for $819.9 million in cash. Valeant expects the deal to close next quarter. In February 2015, Valeant acquired bankrupt Dend...